Developer docs
API playgroundTry for free, no card

Search company profiles

SEGOTIA

Full company profile

uuid000hzu7

Namestring
SEGOTIA
Legal namestring
SEGOTIA LIMITED
Websiteurl
segotia.xyz
Company typeenum
Private
Founded yearint
2017
Descriptiontext

SEGOTIA Limited is a private Irish neuro-audio engineering company, incorporated in the Republic of Ireland (registration 612993) and headquartered at Portershed, Bowling Green, Galway. Founded in 2017 by audio IP and software professionals, the company began as an audio integration specialist for hearables, working on audio engineering for mobile apps and System-on-Chip (SoC) hearables platforms, before pivoting to integrate neuroscience-grade EEG sensing into consumer earbuds. Its core technical differentiator is Ear-EEG technology, supported by a custom in-ear EEG prototype validated in collaboration with Trinity College Dublin, that closes the loop between audio delivery and neural sensing for brain-aware applications in sleep, wellness, and cognitive performance.

The company's product surface consists of a hardware Ear-EEG prototype used for validation, Neuro-Audio application software, and a neuro-enabled earbud under development through a 2-year Eurostars-funded R&D consortium that began in April 2024. SEGOTIA operates a B2B technology licensing and co-development model targeting hearable device manufacturers and NeuroTech/sleep technology companies, distributing globally with regional offices in the United States and mainland Europe. Pricing is not publicly disclosed and no commercial revenue figures are available. The company is small (1–10 employees), relies heavily on academic and institutional partnerships (Trinity College Dublin, leading NeuroScience Institutions, CSEM, Eurostars) for R&D validation, and on January 6, 2026 was acquired by US sleep technology firm Ozlo, which intends to use SEGOTIA's EEG stack to transition from hardware to a platform business and enter the medical device market by 2027, including through a partnership with the Calm meditation app.

Short descriptiontext

SEGOTIA is an Irish neuro-audio engineering company that builds Ear-EEG technology and neuro-adaptive audio software for hearable device manufacturers and NeuroTech customers, and was acquired by OzloSleep in January 2026 to power a sleep and digital health platform.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersGalway, Ireland
HQ citystring
Galway
HQ countrystring
Ireland
HQ regionstring
Europe
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
audio software integration, hearable devices, ear-EEG technology, neuro-audio applications, brain sensing technology
NAICS code1 code
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code1 code
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Neuro-Audio Technology for Hearables
Social media profiles1 record
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

SEGOTIA develops audio processing and neurotechnology for hearable devices, combining audio engineering with neuroscience to create brain-aware (Ear-EEG) sensing capabilities integrated into consumer hearables. The company built a validated in-ear EEG prototype, develops neuro-adaptive audio applications, and licenses its Neuro-Audio technology to hearable device manufacturers and NeuroTech companies for sleep, wellness, and cognitive performance use cases.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

SEGOTIA combines audio processing and neuroscience to drive development of next-generation Hearable Devices and Neuro-adaptive Applications. Their core offerings include an Ear-EEG prototype device, Neuro-Audio Applications for brain-aware hearables, and active development of a neuro-enabled earbud through the Eurostars project. The company integrates neuroscience research and brain wave monitoring capabilities into consumer hearables, closing the loop between audio delivery and neuro sensing, enabling a range of next-generation brain-aware applications.

Product and service2 records
1Neuro-Audio Applications
CategoryNeuro-Audio Software Applications
Description

Brain-aware applications for consumer hearables that integrate EEG sensing with audio delivery, enabling next-generation neuro-adaptive experiences for sleep, wellness, and cognitive performance use cases. Targeted at hearable device manufacturers and NeuroTech companies licensing SEGOTIA's Neuro-Audio platform.

2Ear-EEG Prototype
CategoryHardware Prototype (Reference Design)
Description

Custom in-ear EEG device prototype developed to validate SEGOTIA's neuro-sensing technology for consumer hearables, built in collaboration with Trinity College Dublin. Used to demonstrate Ear-EEG capabilities to potential licensees and partners.

Partnership6 partners
1Ozlo
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2026-01-06
Description

SEGOTIA was acquired by Ozlo in January 2026. The acquisition aims to integrate SEGOTIA's EEG technology into Ozlo's sleep and digital health products. Ozlo plans to use SEGOTIA's technology to enter the medical device market by 2027. SEGOTIA's team and technology will contribute to Ozlo's transition from hardware to platform business.

techcrunch.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-04-01
Description

SEGOTIA participates in a 2-year Eurostars project (starting April 2024) to build a neuro-enabled earbud. Eurostars is a funding program supporting international R&D collaborations.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Long-standing collaboration with Trinity College Dublin for neuroscience research and validation of neuro-enabled earbud technology. Team members include PhD graduates and faculty from Trinity, and Ed Lalor serves as Associate Professor at Trinity College Dublin in the Departments of Biomedical Engineering and Neuroscience.

4Calm
Strategic tierCoreTypeTechnology or Integration
Description

Ozlo announced partnership with Calm meditation app as part of its platform strategy. This partnership is being developed under Ozlo's platform business which incorporates SEGOTIA's neuro-audio technology.

techcrunch.com
Strategic tierMinorTypeStrategic or Co-development Partner
Description

SEGOTIA evaluated CSEM's ULTEEM in-ear EEG hardware as part of their technology assessment process for neuro-enabled earbuds.

6NeuroScience Institutions
Strategic tierCoreTypeStrategic or Co-development Partner
Description

SEGOTIA collaborates with leading NeuroScience Institutions to discover and prove technologies and commercial opportunities in the Neuro-Audio space.

segotia.xyz
Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Consumer EEG headband company focused on meditation, sleep, and brain-monitoring. Directly comparable to SEGOTIA in targeting brain-sensing for consumer audio/wellness use cases, though using a scalp-EEG form factor rather than in-ear.

TypeDirect peer
Description

Sleep-focused EEG wearable that uses brain-sensing to score and improve sleep. Closely comparable to SEGOTIA in sleep-EEG and Ozlo's distribution pathway; competes for the same consumer sleep-tech wallet.

3Apollo Neuroscience
TypeDirect peer
Description

Neurotech company using audio/visual stimulation through a wearable for sleep, calm, and focus. Closely comparable to SEGOTIA's 'neuro-adaptive audio' thesis of using neuroscience to drive audio interventions.

TypeDirect peer
Description

US sleep technology firm and SEGOTIA's acquirer (January 2026). Compares as a direct peer/parent because both target sleep-tech consumers with brain-aware hardware and content; SEGOTIA's EEG IP is now embedded inside Ozlo's platform strategy.

TypeDirect peer
Description

EEG wearables for consumer wellness, research, and B2B applications. Comparable to SEGOTIA in EEG hardware + software stack, though targeting broader BCI/research use cases rather than ear-level hearables.

6Valencell
TypeDirect peer
Description

Licenses biometric sensor technology (PPG, motion, temperature) into hearables and wearables. Directly comparable as a B2B IP licensor enabling sensing features in consumer earbuds — same business model as SEGOTIA's planned hearable-licensing path.

TypeBroad incumbent
Description

Major hearables incumbent with consumer sleep-audio products (SleepBuds). Relevant as a potential customer/partner for SEGOTIA's neuro-audio IP and as a competitor with the resources to internalize EEG.

TypeBroad incumbent
Description

AirPods maker with active health/biometric sensing roadmap. Relevant both as a potential hearable OEM customer for SEGOTIA and as the most consequential competitive risk if Apple ships in-ear EEG.

TypeBroad incumbent
Description

Global hearing-aid leader (Phonak, Unitron) that has begun integrating health/biometric sensors into ear-level devices. Comparable as an ear-level medical-device incumbent with regulatory and distribution scale SEGOTIA lacks.

TypeBroad incumbent
Description

Medical-grade implanted/spiked EEG neurostimulator (RNS System). Comparable as a regulated, EEG-driven medical-device company, illustrating both the regulatory precedent SEGOTIA may face and the regulatory ceiling a sub-scale player must clear.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

SEGOTIA

Neuro-Audio Technology for Hearablessegotia.xyz

SEGOTIA is an Irish neuro-audio engineering company that builds Ear-EEG technology and neuro-adaptive audio software for hearable device manufacturers and NeuroTech customers, and was acquired by OzloSleep in January 2026 to power a sleep and digital health platform.

What SEGOTIA does

SEGOTIA Limited is a private Irish neuro-audio engineering company, incorporated in the Republic of Ireland (registration 612993) and headquartered at Portershed, Bowling Green, Galway. Founded in 2017 by audio IP and software professionals, the company began as an audio integration specialist for hearables, working on audio engineering for mobile apps and System-on-Chip (SoC) hearables platforms, before pivoting to integrate neuroscience-grade EEG sensing into consumer earbuds. Its core technical differentiator is Ear-EEG technology, supported by a custom in-ear EEG prototype validated in collaboration with Trinity College Dublin, that closes the loop between audio delivery and neural sensing for brain-aware applications in sleep, wellness, and cognitive performance.

The company's product surface consists of a hardware Ear-EEG prototype used for validation, Neuro-Audio application software, and a neuro-enabled earbud under development through a 2-year Eurostars-funded R&D consortium that began in April 2024. SEGOTIA operates a B2B technology licensing and co-development model targeting hearable device manufacturers and NeuroTech/sleep technology companies, distributing globally with regional offices in the United States and mainland Europe. Pricing is not publicly disclosed and no commercial revenue figures are available. The company is small (1–10 employees), relies heavily on academic and institutional partnerships (Trinity College Dublin, leading NeuroScience Institutions, CSEM, Eurostars) for R&D validation, and on January 6, 2026 was acquired by US sleep technology firm Ozlo, which intends to use SEGOTIA's EEG stack to transition from hardware to a platform business and enter the medical device market by 2027, including through a partnership with the Calm meditation app.

SEGOTIA firmographics

Firmographics
Name
SEGOTIA
Legal name
SEGOTIA LIMITED
Website
https://segotia.xyz
Company type
Private
Founded year
2017
Operating status
Acquired
Headcount range
1–10 employees
Short description
SEGOTIA is an Irish neuro-audio engineering company that builds Ear-EEG technology and neuro-adaptive audio software for hearable device manufacturers and NeuroTech customers, and was acquired by OzloSleep in January 2026 to power a sleep and digital health platform.
Ownership category
akta.pro rank

Where SEGOTIA is headquartered

Location

Headquarters

HQ city
Galway
HQ country
Ireland
HQ region
Europe

Offices3 records

Markets served

SEGOTIA business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales

Distribution channels1 record

Marketing channels3 records

SEGOTIA product offering

Product offering

Core offering

SEGOTIA develops audio processing and neurotechnology for hearable devices, combining audio engineering with neuroscience to create brain-aware (Ear-EEG) sensing capabilities integrated into consumer hearables. The company built a validated in-ear EEG prototype, develops neuro-adaptive audio applications, and licenses its Neuro-Audio technology to hearable device manufacturers and NeuroTech companies for sleep, wellness, and cognitive performance use cases.

Product overview

SEGOTIA combines audio processing and neuroscience to drive development of next-generation Hearable Devices and Neuro-adaptive Applications. Their core offerings include an Ear-EEG prototype device, Neuro-Audio Applications for brain-aware hearables, and active development of a neuro-enabled earbud through the Eurostars project. The company integrates neuroscience research and brain wave monitoring capabilities into consumer hearables, closing the loop between audio delivery and neuro sensing, enabling a range of next-generation brain-aware applications.

Differentiator

Problem solved

Functional benefit

Products and services

  • Neuro-Audio Applications Brain-aware applications for consumer hearables that integrate EEG sensing with audio delivery, enabling next-generation neuro-adaptive experiences for sleep, wellness, and cognitive performance use cases. Targeted at hearable device manufacturers and NeuroTech companies licensing SEGOTIA's Neuro-Audio platform.
  • Ear-EEG Prototype Custom in-ear EEG device prototype developed to validate SEGOTIA's neuro-sensing technology for consumer hearables, built in collaboration with Trinity College Dublin. Used to demonstrate Ear-EEG capabilities to potential licensees and partners.

Companies that use SEGOTIA

Customer profile

Segments2 records

Ideal customer profiles2 records

SEGOTIA technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature3 records

SEGOTIA partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered flagship, core and minor.

  • OzloflagshipStrategic or Co-development Partner · 6 January 2026SEGOTIA was acquired by Ozlo in January 2026. The acquisition aims to integrate SEGOTIA's EEG technology into Ozlo's sleep and digital health products. Ozlo plans to use SEGOTIA's technology to enter the medical device market by 2027. SEGOTIA's team and technology will contribute to Ozlo's transition from hardware to platform business.
  • EurostarscoreStrategic or Co-development Partner · 1 April 2024SEGOTIA participates in a 2-year Eurostars project (starting April 2024) to build a neuro-enabled earbud. Eurostars is a funding program supporting international R&D collaborations.
  • Trinity College DublincoreStrategic or Co-development PartnerLong-standing collaboration with Trinity College Dublin for neuroscience research and validation of neuro-enabled earbud technology. Team members include PhD graduates and faculty from Trinity, and Ed Lalor serves as Associate Professor at Trinity College Dublin in the Departments of Biomedical Engineering and Neuroscience.
  • CalmcoreTechnology or IntegrationOzlo announced partnership with Calm meditation app as part of its platform strategy. This partnership is being developed under Ozlo's platform business which incorporates SEGOTIA's neuro-audio technology.
  • CSEMminorStrategic or Co-development PartnerSEGOTIA evaluated CSEM's ULTEEM in-ear EEG hardware as part of their technology assessment process for neuro-enabled earbuds.
  • NeuroScience InstitutionscoreStrategic or Co-development PartnerSEGOTIA collaborates with leading NeuroScience Institutions to discover and prove technologies and commercial opportunities in the Neuro-Audio space.

Recent moves5 records

Expansion highlights5 records

SEGOTIA competitors and assessment

Company assessment

Direct peers

  • Muse: Consumer EEG headband company focused on meditation, sleep, and brain-monitoring. Directly comparable to SEGOTIA in targeting brain-sensing for consumer audio/wellness use cases, though using a scalp-EEG form factor rather than in-ear.
  • Dreem: Sleep-focused EEG wearable that uses brain-sensing to score and improve sleep. Closely comparable to SEGOTIA in sleep-EEG and Ozlo's distribution pathway; competes for the same consumer sleep-tech wallet.
  • Apollo Neuroscience: Neurotech company using audio/visual stimulation through a wearable for sleep, calm, and focus. Closely comparable to SEGOTIA's 'neuro-adaptive audio' thesis of using neuroscience to drive audio interventions.
  • Ozlo: US sleep technology firm and SEGOTIA's acquirer (January 2026). Compares as a direct peer/parent because both target sleep-tech consumers with brain-aware hardware and content; SEGOTIA's EEG IP is now embedded inside Ozlo's platform strategy.
  • Emotiv: EEG wearables for consumer wellness, research, and B2B applications. Comparable to SEGOTIA in EEG hardware + software stack, though targeting broader BCI/research use cases rather than ear-level hearables.
  • Valencell: Licenses biometric sensor technology (PPG, motion, temperature) into hearables and wearables. Directly comparable as a B2B IP licensor enabling sensing features in consumer earbuds — same business model as SEGOTIA's planned hearable-licensing path.

Broad incumbents

  • Bose: Major hearables incumbent with consumer sleep-audio products (SleepBuds). Relevant as a potential customer/partner for SEGOTIA's neuro-audio IP and as a competitor with the resources to internalize EEG.
  • Apple: AirPods maker with active health/biometric sensing roadmap. Relevant both as a potential hearable OEM customer for SEGOTIA and as the most consequential competitive risk if Apple ships in-ear EEG.
  • Sonova: Global hearing-aid leader (Phonak, Unitron) that has begun integrating health/biometric sensors into ear-level devices. Comparable as an ear-level medical-device incumbent with regulatory and distribution scale SEGOTIA lacks.
  • NeuroPace: Medical-grade implanted/spiked EEG neurostimulator (RNS System). Comparable as a regulated, EEG-driven medical-device company, illustrating both the regulatory precedent SEGOTIA may face and the regulatory ceiling a sub-scale player must clear.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights5 records

Customer concentration

SEGOTIA social profiles

Digital presence

SEGOTIA financial estimates

Financial estimate

Revenue estimate

Valuation estimate

SEGOTIA leadership team

Management profile

Number of profiles

Profiles5 records

SEGOTIA funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

SEGOTIA M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SEGOTIA

What does SEGOTIA do?

SEGOTIA develops audio processing and neurotechnology for hearable devices, combining audio engineering with neuroscience to create brain-aware (Ear-EEG) sensing capabilities integrated into consumer hearables. The company built a validated in-ear EEG prototype, develops neuro-adaptive audio applications, and licenses its Neuro-Audio technology to hearable device manufacturers and NeuroTech companies for sleep, wellness, and cognitive performance use cases.

Is SEGOTIA a public or private company?

SEGOTIA is a private company. It is classified as corporate owned and is currently acquired.

When was SEGOTIA founded?

SEGOTIA was founded in 2017. It employs 1 to 10 people.

Where is SEGOTIA based?

SEGOTIA is headquartered in Galway, Ireland, in the Europe region.

Who are SEGOTIA's main competitors?

Direct peers on record are Muse, Dreem, Apollo Neuroscience, Ozlo, Emotiv and Valencell. Broad incumbents are Bose, Apple, Sonova and NeuroPace.

Does SEGOTIA have an API?

No public API is recorded for SEGOTIA.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Mugglehead MagazineOzlo enhances its ‘Sleepbuds’ by acquiring Irish neurotech company SegotiaOzlo has acquired Ireland-based neurotech company Segotia to establish a dedicated neuroscience research and development hub. This acquisition will enable Ozlo to integrate EEG brain-monitoring technology into its Sleepbuds, with a new product launching next year.TechCrunchHow the Sleepbuds maker, Ozlo, is building a platform for sleep dataOzlo, the maker of Sleepbuds, announced at CES in Las Vegas its transition from a hardware company into a platform business, highlighted by a partnership with meditation app Calm and the acquisition of Irish neurotech startup Segotia. The company plans to expand into software subscriptions including AI-powered features and tinnitus therapy (launching Q2 2026), while also developing new hardware products and an AI sleep agent. Ozlo is currently closing a Series B funding round and aims to enter the medical device market by 2027 using Segotia's EEG technology.Silicon RepublicUS firm Ozlo buys Galway’s Segotia to innovate sleep wearablesUS-based sleep technology company Ozlo has acquired Galway-based neurotech firm Segotia, an audio integration creator for hearables, with terms undisclosed. Segotia will serve as Ozlo's neuroscience R&D hub to help accelerate its product roadmap and enable brain-health monitoring through its earbud form factor. The nearly $30 billion sleep-tech market, led by wearables like Apple Watch and Oura rings, is projected to grow to over $100 billion by 2033.FittOzlo Expands Neuroscience Capabilities with Acquisition of SegotiaOzlo, maker of Sleepbuds, has acquired Segotia, an Ireland-based neuroscience and technology company, to establish a dedicated neuroscience R&D hub focused on studying brain activity during sleep. The acquisition enables Ozlo to leverage Segotia's expertise in hearable technologies and academic partnerships to develop predictive brain-health signals in consumer-grade ear-based devices, with potential therapeutic applications for sleep-related medical conditions. Segotia's team will join Ozlo while continuing to build on the company's existing product platform and long-term vision for sleep and digital health products.